Press releases

TRIPLAN sets the course for a successful future

Bad Soden, 29 April 2005.
Initial future-oriented measures were decided on from 1 July 2005 with the rejuvenation of the engineering board and the planned issue of a convertible loan with a total volume of up to 2.6 m Euro as part of a rights issue.

This is because revenue from the capital adjustment will be used to finance growth, including expanding essential business areas (food and animal feed), expanding sales within the EU, building up capacity in our Prague subsidiary and improving liquidity. We are debt-free except for supplier’s invoices from daily business. Our equity ratio is 51.2 %.

The test phase of our Swiss subsidiary, TRIPLAN Ingenieur AG, Basel has shown promising results: A range of services can be offered better by integrating the engineering capacities of TRIPLAN Prague with lower hourly engineering rates. A successful model: We managed to record excellent incoming orders/fees of 7.1 m CHF in just under four months in 2005. Our client is the Basel-based pharmaceuticals and biotech industry, with which we have been working continuously for some 30 years. TRIPLAN AG Deutschland will take over the Swiss model. This will mean a corresponding increase in the engineering capacity of TRIPLAN Prague.

The TRIPLAN Group is currently working at full capacity. The company also sees growing order opportunities including from cooperation with sector-specific companies whose business fields complement ours.

Contact:
TRIPLAN AG
Auf der Krautweide 32
65812 Bad Soden

Phone: +49 6196 / 60 92 - 0
Fax: +49 6196 / 60 92 - 203
e-mail: info@triplan.com